Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada: cardiovascular disease in COPD patients
…, C DeLuise, JK Jones, S Lanes, MR Stang… - Annals of …, 2006 - Elsevier
PURPOSE: To measure prevalence, incidence, and mortality of cardiovascular outcomes
among persons with chronic obstructive pulmonary disease (COPD) and to assess the extent …
among persons with chronic obstructive pulmonary disease (COPD) and to assess the extent …
Epidemiology of diabetes mellitus among First Nations and non-First Nations adults
… Mary Rose Stang helped design the study and acquired the data. Nathaniel Osgood …
Nathaniel Osgood, Ting Hsiang Lin, Mary Rose Stang and Amy Gao revised the manuscript …
Nathaniel Osgood, Ting Hsiang Lin, Mary Rose Stang and Amy Gao revised the manuscript …
Use of antidepressants and risk of colorectal cancer: a nested case-control study
W Xu, H Tamim, S Shapiro, MR Stang… - The lancet oncology, 2006 - thelancet.com
Background Animal studies suggest that selective serotonin reuptake inhibitors (SSRI)
retard the growth of colorectal tumours, whereas tricyclic antidepressants increase the risk of …
retard the growth of colorectal tumours, whereas tricyclic antidepressants increase the risk of …
Chronic obstructive pulmonary disease severity and cardiovascular outcomes
SM Curkendall, S Lanes, C de Luise, MR Stang… - European journal of …, 2006 - Springer
Objective: To identify predictors of chronic obstructive pulmonary disease (COPD) severity
and assess the relation between COPD severity and risk of cardiovascular outcomes. Study …
and assess the relation between COPD severity and risk of cardiovascular outcomes. Study …
Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
…, JL Blackburn, TW Wilson, MR Stang… - The Canadian journal …, 2005 - europepmc.org
Background Population studies of statin adherence are generally restricted to one to two
years of follow-up and do not analyze adherence to other drugs. Objectives To report long-term …
years of follow-up and do not analyze adherence to other drugs. Objectives To report long-term …
Positive predictive value of ICD‐9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database
…, J Castellsague, MR Stang… - … and drug safety, 2008 - Wiley Online Library
Positive predictive value of ICDâ•’9 codes 410 and 411 in the identification of cases of acute
coronary syndromes in the Sa Page 1 ORIGINAL REPORT Positive predictive value of ICD-…
coronary syndromes in the Sa Page 1 ORIGINAL REPORT Positive predictive value of ICD-…
Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis
… Mary Rose Stang helped design the study and acquired the data. Roland Dyck acquired
the data, co-conceived and helped design the study, interpreted the data, oversaw the project …
the data, co-conceived and helped design the study, interpreted the data, oversaw the project …
[PDF][PDF] Health databases in Saskatchewan
…, P Beck, M McNutt, MR Stang… - …, 2000 - pharmdblog-87.webself.net
Saskatchewan is one of ten provinces and three territories in Canada. It is located in western
Canada and has a stable population of about one million people, or 3.4% of the total …
Canada and has a stable population of about one million people, or 3.4% of the total …
The relationship between diabetes and tuberculosis in Saskatchewan: comparison of registered Indians and other Saskatchewan people
…, H Klomp, DD Marciniuk, L Tan, MR Stang… - Canadian journal of …, 2007 - Springer
Background Saskatchewan Aboriginal people are experiencing epidemics of both type 2
diabetes (T2DM) and tuberculosis (TB). The purpose of this study was to determine if a …
diabetes (T2DM) and tuberculosis (TB). The purpose of this study was to determine if a …
The use of selective cyclooxygenase‐2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada
…, J Castellsague, MR Stang… - … and Drug Safety, 2009 - Wiley Online Library
Background Meta‐analyses of observational studies show variability in the risk of acute
myocardial infarction (AMI) among non‐steroidal anti‐inflammatory drugs (NSAIDs), with an …
myocardial infarction (AMI) among non‐steroidal anti‐inflammatory drugs (NSAIDs), with an …